Results 131 to 140 of about 125,716 (297)

Postoperative association between impaired renal function and vascular dysfunction in liver transplant recipients

open access: yes, 2022
Liver Transplantation, EarlyView.
Domenico A. Chavez   +8 more
wiley   +1 more source

Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis

open access: yesFrontiers in Endocrinology
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by impaired ...
Bruno Ramos-Molina   +16 more
doaj   +1 more source

Discovery of (E)-3-(3-((2-Cyano-4′-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis

open access: green, 2022
Soyeon Shim   +14 more
openalex   +2 more sources

Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice

open access: gold, 2022
Xinyu Bao   +13 more
openalex   +1 more source

Sex-specific effects of peptidyl arginine deiminase 4 deficiency in the cafeteria diet-induced obesity-associated metabolic complications

open access: yesFrontiers in Endocrinology
BackgroundObesity is a global health challenge linked to chronic non-communicable diseases. Low-grade inflammation and altered immune responses, including neutrophil extracellular trap (NET) formation, contribute to metabolic complications.
Andrej Feješ   +9 more
doaj   +1 more source

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

open access: yesAmerican Journal of Gastroenterology, 1999
E. Brunt   +4 more
semanticscholar   +1 more source

Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial

open access: yesNature Medicine, 2021
S. Harrison   +12 more
semanticscholar   +1 more source

CT-based radiomics-clinical model for risk assessment of parenteral nutrition-associated hepatic steatosis in chronic intestinal failure and its metabolomic interpretation

open access: yesFrontiers in Nutrition
BackgroundPatients with chronic intestinal failure (CIF) dependent on parenteral nutrition (PN) are at risk of developing parenteral nutrition-associated hepatic steatosis (PNAHS), a condition that can progress to hepatic fibrosis.
Yufei Xia   +13 more
doaj   +1 more source

Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients [PDF]

open access: gold, 2023
Hua-Chien Wu   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy